Potential role of cannabinoids
in Parkinson's disease
by
Sevcik J, Masek K
Institute of Pharmacology,
Academy of Sciences of the Czech Republic,
Prague.
sevcik@biomed.cas.cz
Drugs Aging 2000 Jun; 16(6): 391-5
ABSTRACTParkinson's disease (PD) is a neurodegenerative disorder caused by a progressive loss of dopaminergic neurons of the substantia nigra, resulting from an oxidative stress. The lack of dopaminergic neurons is reflected by a disturbed balance of the neural circuitry in the basal ganglia. Cannabinoids might alleviate some parkinsonian symptoms by their remarkable receptor-mediated modulatory action in the basal ganglia output nuclei. Moreover, it was recently observed that some cannabinoids are potent antioxidants that can protect neurons from death even without cannabinoid receptor activation. It seems that cannabinoids could delay or even stop progressive degeneration of brain dopaminergic systems, a process for which there is presently no prevention. In combination with currently used drugs, cannabinoids might represent, qualitatively, a new approach to the treatment of PD, making it more effective.Bliss
Aerosol
URB597
Plants/CNS
Anandamide
Just say know
Tolerant mice
Forgetful rodents
Endocannabinoids
Stoned as a newt?
Keen-eyed goldfish
The nectar of delight
Stoned chocaholics?
Humans are not rats
Cannabinoid receptors
Cannabis Abuse Disorder
Cannabis and schizophrenia01 02 03 04 05 06 07 08 09 10 11 12 13 14 15
Refs
HedWeb
Future Opioids
BLTC Research
Paradise-Engineering
Utopian Pharmacology
The Hedonistic Imperative
When Is It Best To Take Crack Cocaine?
The Good Drug Guide
The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family
